Connelly v. Hayashi CA4/3

CourtCalifornia Court of Appeal
DecidedJuly 24, 2013
DocketG046247
StatusUnpublished

This text of Connelly v. Hayashi CA4/3 (Connelly v. Hayashi CA4/3) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Connelly v. Hayashi CA4/3, (Cal. Ct. App. 2013).

Opinion

Filed 7/24/13 Connelly v. Hayashi CA4/3

NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FOURTH APPELLATE DISTRICT

DIVISION THREE

SCOTT CONNELLY,

Cross-complainant and Appellant, G046247

(Super. Ct. No. 30-2010-00371616) v. OPINION JOE HAYASHI et al.,

Cross-defendants and Respondents.

Appeal from a judgment of the Superior Court of Orange County, Nancy Wieben Stock, Judge. Reversed. Krane & Smith, Samuel Krane and Ralph C. Loeb; Law Offices of Becky Walker James, Becky Walker James and Kathryn Lohmeyer for Cross-complainant and Appellant. Klinedinst, Heather L. Rosing and David M. Majchrzak for Cross- defendants and Respondents. * * * Cross-complainant Scott Connelly alleges cross-defendant Joe Hayashi, Connelly’s alleged attorney, committed fraud and breached fiduciary duties. Hayashi was hired to draw up the paperwork creating a new business venture between Connelly and various individuals. Hayashi allegedly deceived Connelly as to the identity of one of the individuals involved in the business who was recently convicted of criminal fraud in connection with other business dealings. Hayashi also allegedly misrepresented the nature of one the agreements Connelly signed, resulting in the contribution of assets to the new venture Connelly had not intended. Connelly did not read the agreement before signing it, relying instead on Hayashi’s representations of what it contained. Hayashi also allegedly fraudulently induced Connelly to refrain from timely serving a “reversion notice” that would have unwound the whole transaction. The court sustained demurrers to various causes of action sounding in fraud and professional negligence. The allegedly fraudulently-induced agreement, which was attached to the cross-complaint, stated that Hayashi did not represent Connelly, only the newly formed entity. The court ruled Connelly was bound by that admission, and, as a result, Connelly could not assert professional negligence claims. Nor could Connelly establish justifiable reliance for the fraud claims due to his failure to read the agreement. The court also found the fraud claims lacked specificity. We reverse. Connelly’s allegations establish an implied attorney-client relationship with Hayashi. Connelly is not bound by contrary “admissions” in the agreement he signed. Normally facts in an attached exhibit trump contrary facts alleged in a complaint. But that rule does not apply here because Connelly did not merely attach the agreement, but did so claiming it was fraudulent. Further, Connelly’s failure to read the agreement does not preclude justifiable reliance on a misrepresentation by a fiduciary. Finally, we conclude Connelly adequately pleaded fraud, with one exception. For one of his causes of action, he has not adequately pleaded damages, but as to that cause of action we reverse the order denying leave to amend.

2 1 FACTS

Connelly is a physician and leading expert in the field of human nutrition and metabolism. He is the inventor of the MET-Rx high protein, low-fat vitamin and mineral enriched drink. For more than a decade, Connelly has researched the development of medical products from specific dairy bioactive whey protein fractions to exploit their regenerative properties. In 2001, Connelly identified a specific dairy bioactive fraction, “lactoferrin,” and contracted with a research group to produce it. After receiving a suitable sample of the protein fraction, Connelly contracted with Brigham and Women’s Hospital in Boston to perform standard rodent testing using lactoferrin. The positive results from that study led Connelly to find a manufacturing partner to commercialize lactoferrin. That partner turned out to be cross-defendant Murray Gouldburn Co- 2 operative Co. (“Murray Gouldburn”), the largest processor of milk in Australia. Murray Gouldburn perfected industrial methodologies to produce a dairy protein fraction containing lactoferrin, called Whey Growth Factor Extract (“WGFE”). Connelly and Murray Gouldburn formed a joint venture and sold WGFE on a small scale under the brand “Progenex.” A few years later, Connelly and Murray Gouldburn decided to seek additional financing to expand the operation. During the search, Connelly met cross- 3 defendants Adam Stuart Zuckerman and Ryan Page. Zuckerman referred to himself as

1 The following facts taken from Connelly’s various cross-complaints are assumed to be true for purposes of this appeal. 2 Murray Gouldburn is not a party to this appeal. 3 Zuckerman and Page are not parties to this appeal.

3 “Adam Stuart” to conceal his identity because Zuckerman had recently been convicted of felony fraud in connection with a business operation. Zuckerman and Page claimed they could raise the funding Connelly sought through various entities they were affiliated with. After further discussions, Connelly, Zuckerman, and Page agreed to set up a new company to further develop and commercialize products being sold under the Progenex brand name. Zuckerman and Page agreed to raise $5 million, and Connelly agreed to invest $1million to be used exclusively for medical research and to transfer intellectual property rights associated with Progenex to the joint venture. Subsequently, Connelly, Zuckerman, and Page discussed the importance of speaking to an attorney to form the proposed joint venture and prepare all agreements related to the venture. To that end, Zuckerman and Page introduced Connelly to Joe Hayashi, a partner at the law firm Fortis General Counsel, LLP (“Fortis”) as an attorney who could handle the various legal matters they discussed. Over the next few months, on several occasions Page, Zuckerman, and Connelly met with Hayashi to discuss implementation of the deal. Connelly deemed these conversations to be confidential. During these conversations, Hayashi expressly stated he was looking out for Connelly’s interests. The parties discussed the assets Connelly would bring to the table together with Connelly’s goals and purposes for participating in the deal. Zuckerman and Page were present during these conversations. Hayashi provided legal advice to Connelly. The legal advice Hayashi provided to Connelly concerned such topics as Connelly’s rights in connection with the deal; the formation, ownership, and governance of the new entity; the use and protection of intellectual property and funds invested or to be invested by Connelly; and the rights and obligations between and among Connelly, VenturePharma (a participating company controlled by Zuckerman and Page), and Murray Gouldburn.

4 Hayashi also agreed to perform legal services on Connelly’s behalf. For example, Hayashi, at Connelly’s request, prepared an agreement (“Contribution Agreement”), which documented, among other things, Connelly’s contribution of assets and intellectual property to the new company. Connelly specifically directed Hayashi to clarify in the Contribution Agreement that Connelly was not contributing his “BodyRx” branded products and that Connelly was not responsible for raising money for the new venture. Hayashi agreed to prepare the agreement consistent with Connelly’s wishes. Also, Hayashi agreed, at Connelly’s request, to prepare the appropriate documentation reflecting that Connelly’s $1 million investment would be used principally to fund certain medical studies concerning Progenex (the parties refer to this as the “Investment Agreement”). As a result of these interactions, Connelly believed Hayashi was his attorney.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

AREI II Cases
216 Cal. App. 4th 1004 (California Court of Appeal, 2013)
Speegle v. Board of Fire Underwriters
172 P.2d 867 (California Supreme Court, 1946)
Serrano v. Priest
487 P.2d 1241 (California Supreme Court, 1971)
Davis v. State Bar
655 P.2d 1276 (California Supreme Court, 1983)
Lazar v. Superior Court
909 P.2d 981 (California Supreme Court, 1996)
Committee on Children's Television, Inc. v. General Foods Corp.
673 P.2d 660 (California Supreme Court, 1983)
Heckendorn v. City of San Marino
723 P.2d 64 (California Supreme Court, 1986)
Blank v. Kirwan
703 P.2d 58 (California Supreme Court, 1985)
Neel v. Magana, Olney, Levy, Cathcart & Gelfand
491 P.2d 421 (California Supreme Court, 1971)
Tormo v. Yormark
398 F. Supp. 1159 (D. New Jersey, 1975)
Cooper v. Leslie Salt Co.
451 P.2d 406 (California Supreme Court, 1969)
Hecht v. Superior Court
192 Cal. App. 3d 560 (California Court of Appeal, 1987)
Houston General Insurance v. Superior Court
108 Cal. App. 3d 958 (California Court of Appeal, 1980)
Del E. Webb Corp. v. Structural Materials Co.
123 Cal. App. 3d 593 (California Court of Appeal, 1981)
Miller v. Metzinger
91 Cal. App. 3d 31 (California Court of Appeal, 1979)
Dodd v. Citizens Bank of Costa Mesa
222 Cal. App. 3d 1624 (California Court of Appeal, 1990)
SARALE v. Pacific Gas & Electric Co.
189 Cal. App. 4th 225 (California Court of Appeal, 2010)
Wald v. TRUSPEED MOTORCARS, LLC
184 Cal. App. 4th 378 (California Court of Appeal, 2010)
Williams v. Southern California Gas Co.
176 Cal. App. 4th 591 (California Court of Appeal, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Connelly v. Hayashi CA4/3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/connelly-v-hayashi-ca43-calctapp-2013.